CHICAGO & ITASCA, Ill., June 22, 2026--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. ...
The collaboration will evaluate Ajinomoto Group’s stem cell culture products using Syntax Bio’s programmable stem cell differentiation platform to support improved regenerative medicine discovery, ...
Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform The collaboration will evaluate Ajinomoto Group’s stem ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results